Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
User Experience of an Innovative Mobile Health Program to Assist in Insulin Dose Adjustment: Outcomes of a Proof-Of-Concept Trial Publisher Pubmed



Ding H1 ; Fatehi F1, 2, 3 ; Russell AW4, 5 ; Karunanithi M1 ; Menon A2, 4 ; Bird D2 ; Gray LC2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Australian E-Health Research Centre, CSIRO, Level 5-UQ Health Sciences Building 901/16, Royal Brisbane and Women's Hospital, Brisbane, Herston, 4029, Australia
  2. 2. Centre for Online Health, Centre for Health Services Research, Faculty of Medicine, University of Queensland, Brisbane, Australia
  3. 3. Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Diabetes and Endocrinology, Princess Alexandra Hospital, Brisbane, Australia
  5. 5. Faculty of Medicine, University of Queensland, Brisbane, Australia

Source: Telemedicine and e-Health Published:2018


Abstract

Background: Many patients with diabetes require insulin therapy to achieve optimal glycemic control. Initiation and titration of insulin often require an insulin dose adjustment (IDA) program, involving frequent exchange of blood glucose levels (BGLs) and insulin prescription advice between the patient and healthcare team. This process is time consuming with logistical barriers. Objective: To develop an innovative mobile health (m-Health) mobile-based IDA program (mIDA) and evaluate the user adherence and experience through a proof-of-concept trial. Methods: In the program, an m-Health system was designed to be integrated within a clinical IDA service, comprising a Bluetooth-enabled glucose meter, smartphone application, and clinician portal. Insulin-requiring patients with type-2 diabetes mellitus and stable BGL were recruited to use the m-Health system to record and exchange BGL entries, insulin dosages, and clinical messages for 2 weeks. The user experience was evaluated by a Likert scale questionnaire. Results: Nine participants, aged 58 ± 14 years (mean ± SD), completed the trial with average daily records of 3.1 BGL entries and 1.2 insulin dosage entries. The participants recognized the potential value of the clinical messages. They felt confident about managing their diabetes and were positive regarding ease of use and family support of the system, but disagreed that there were no technical issues. Finally, they were satisfied with the program and would continue to use it if possible. Conclusions: The m-Health system for IDA showed promising levels of adherence, usability, perception of usefulness, and satisfaction. Further research is required to assess the feasibility and cost-effectiveness of using this system in outpatient settings. © Copyright 2018, Mary Ann Liebert, Inc. 2018.
Related Docs
1. Diabetes Care in the Digital Era: A Synoptic Overview, Current Diabetes Reports (2018)
2. Conformity of Diabetes Mobile Apps With the Chronic Care Model, BMJ Health and Care Informatics (2019)
3. Determining Minimum Set of Features for Diabetes Mobile Apps, Journal of Diabetes and Metabolic Disorders (2019)
4. Usability of a Disease Management Mobile Application As Perceived by Patients With Diabetes, CIN - Computers Informatics Nursing (2019)
5. Outcomes of a Feasibility Trial Using an Innovative Mobile Health Programme to Assist in Insulin Dose Adjustment, BMJ Health and Care Informatics (2019)
6. Rethinking Models of Outpatient Specialist Care in Type 2 Diabetes Using Ehealth: Study Protocol for a Pilot Randomised Controlled Trial, International Journal of Environmental Research and Public Health (2019)
7. Validity Study of Video Teleconsultation for the Management of Diabetes: A Pilot Randomized Controlled Trial, Diabetes Technology and Therapeutics (2015)
8. Mobile Health (Mhealth) for Diabetes Care: Opportunities and Challenges, Diabetes Technology and Therapeutics (2017)
Experts (# of related papers)
Sharareh Rostam Niakan Kalhori (2)
Marjan Ghazisaeedi (2)